Assessing the impact of the COVID-19 pandemic on bowel cancer services
15 January 2021
Thousands of patients may have undiagnosed and untreated bowel cancer due to COVID-19 disruption.
Roadmap to the Future
16 December 2020
Professor Fergus Gleeson participates in a panel discussion at this webinar launching the Early Detection and Diagnosis Roadmap.
Investigating the effects of co-morbidities on liver cancer risk
15 December 2020
Dr Philippa Matthews and colleagues review the associations between liver cancer risk and co-morbidities and other metabolic factors in individuals with chronic hepatitis B virus infection.
Potential of DNA-based blood tests for detecting pancreatic cancer earlier
11 December 2020
Dr Shivan Sivakumar and colleagues evaluate the current progress and future potential in using genetic and epigenetic methods for detecting pancreatic cancer DNA in the blood.
Studying prostate cancer risk in the UK Biobank
7 December 2020
Dr Eleanor Watts investigates the prostate cancer incidence and mortality risks associated with blood levels of insulin-like growth factor-1 and testosterone.
The impact of COVID-19 on breast cancer diagnoses
2 December 2020
Dr Toral Gathani leads a study into the scale of the diagnostic delays in England.
Collating clinical data for liver disease research
2 December 2020
The NIHR Health Informatics Collaborative Viral Hepatitis theme led by Professor Ellie Barnes has developed a pipeline to build a database of electronic clinical data that can support research into viral hepatitis and associated liver complications.
Bioengineering the human gut
2 December 2020
An interdisciplinary collaboration generates an advanced model of the human gastrointestinal tract with broad applications for disease research and regenerative medicine.
Using AI to improve the quality of endoscopy videos
25 November 2020
A multidisciplinary team of researchers has developed a deep-learning framework for improving endoscopy to aid cancer detection.
In conversation with Xin Lu
16 November 2020
OxCODE Director Professor Xin Lu features in this edition of the FEBS Journal.
OxCODE researchers present at NCRI 2020
10 November 2020
Oxford early detection researchers showcase their work at the National Cancer Research Institute’s annual conference.
New estimates of breast cancer risks associated with HRT
2 November 2020
A study by Oxford’s Professor Julia Hippisley-Cox and colleagues at the University of Nottingham adds to existing knowledge and should help doctors and women make the best treatment choices.
$410 million buy out for Oxford cancer detection technology
30 October 2020
Oxford spin-out Base Genomics is acquired by early cancer detection company Exact Sciences.
CRUK Oxford Centre Symposium 2020
27 October 2020
Oxford’s early detection research is highlighted at this year’s virtual gathering of the Oxford cancer community.
Roadmap for early detection
26 October 2020
Cancer Research UK presents the Early Detection and Diagnosis of Cancer Roadmap, with contributions from OxCODE researchers.
Funding boost for OxPLoreD early detection study
20 October 2020
UK Research and Innovation provides additional funds for whole genome sequencing as part of the OxPLoreD programme of research into high-risk conditions for blood cancer.
OxCODE researchers at the Early Detection of Cancer Conference 2020
16 October 2020
Oxford’s early detection research was featured at this annual event.
Tumour evolution has implications for liquid biopsy
13 October 2020
A study of prostate cancer evolution during metastasis observes that liquid biopsies do not capture the complete genetic diversity of the disease within a patient.
OxCODE Associate Director appointed as Professor
13 October 2020
Congratulations to Professor Simon Leedham who has been appointed to the Professorship of Molecular and Population Genetics.
Oxfordshire-based SCAN pathway wins BMJ award
8 October 2020
A pathway designed to investigate individuals with non-specific but concerning symptoms of cancer wins the BMJ Awards 2020 Cancer Care Team of the Year.